ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2023
Zinzino group revenue increased with a total of 24%, compared with the previous year.
The revenue in February for Zinzino's sales markets increased by 23 % and amounted to SEK 109.6 (89.0) million. Faun Pharma's external sales increased by 34 % and amounted to SEK 8.7 (6.5) million. Overall, the Group increased revenues by 24 % to SEK 118.3 (95.5) million compared with the previous year.
Accumulated revenue for January – February 2023 increased by 21% to SEK 247.7 (204.5) million.
Revenues were distributed as follows:
| Regions,MSEK | 23-Feb | 22-Feb | Change | YTD 2023 | YTD 2022 | Change |
| The Nordics | 23.2 | 21.5 | 8% | 46.7 | 47.5 | -2% |
| Central Europe | 26.9 | 18.5 | 45% | 55.4 | 36.9 | 50% |
| East Europe | 25.2 | 23.3 | 8% | 58.0 | 52.0 | 12% |
| South & West Europe | 14.4 | 11.2 | 29% | 30.3 | 23.3 | 30% |
| The Baltics | 6.0 | 5.2 | 15% | 13.4 | 11.6 | 16% |
| North America | 6.5 | 4.3 | 51% | 12.8 | 8.7 | 47% |
| Asia-Pacific | 6.4 | 4.6 | 39% | 10.9 | 10.3 | 6% |
| Africa | 1.0 | 0.4 | 150% | 2.4 | 0.8 | 200% |
| Zinzino | 109.6 | 89.0 | 23% | 229.9 | 191.1 | 20% |
| Faun Pharma | 8.7 | 6.5 | 34% | 17.8 | 13.4 | 33% |
| Zinzino Group | 118.3 | 95.5 | 24% | 247.7 | 204.5 | 21% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino owns the Swiss, biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, the US and Australia.